163 related articles for article (PubMed ID: 7408260)
21. Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism.
Esposito MG; Cesare CM; De Santo RM; Cice G; Perna AF; Violetti E; Conzo G; Bilancio G; Celsi S; Annunziata F; Iannelli S; De Santo NG; Cirillo M; Livrea A
J Nephrol; 2008; 21 Suppl 13():S92-6. PubMed ID: 18446739
[TBL] [Abstract][Full Text] [Related]
22. Factors modulating cytosolic calcium. Role in lipid metabolism and cardiovascular morbidity and mortality in peritoneal dialysis patients.
Gadallah MF; el-Shahawy M; Andrews G; Ibrahim M; Ramdeen G; Hanna D; Gorospe W; Morkos A; Abbassian M; Moles K
Adv Perit Dial; 2001; 17():29-36. PubMed ID: 11510292
[TBL] [Abstract][Full Text] [Related]
23. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
Chow TL; Chan TT; Ho YW; Lam SH
Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
[TBL] [Abstract][Full Text] [Related]
24. Simultaneous lowering of serum phosphate and LDL-cholesterol by sevelamer hydrochloride (RenaGel) in dialysis patients.
Wilkes BM; Reiner D; Kern M; Burke S
Clin Nephrol; 1998 Dec; 50(6):381-6. PubMed ID: 9877112
[TBL] [Abstract][Full Text] [Related]
25. Ratio of cyclase activating and cyclase inactive parathormone (CAP/CIP) in dialysis patients: correlations with other markers of bone disease.
Grzegorzewska AE; Młot M
Rocz Akad Med Bialymst; 2004; 49():190-2. PubMed ID: 15631341
[TBL] [Abstract][Full Text] [Related]
26. Cimetidine and circulating calciotropic hormone levels in uremic patients: evidence for a suppressive effect on calcitonin secretion.
Sebert JL; Decourcelles PH; Morinière P; Calmette C; Gueris J; Makdassi R; Khassouf J; Andrejak M; Fournier A
Miner Electrolyte Metab; 1982 Dec; 8(6):293-9. PubMed ID: 7167135
[TBL] [Abstract][Full Text] [Related]
27. Chronic hemofiltration. A critical evaluation of a new method for the treatment of blood.
Schaefer K; von Herrath D; Gullberg CA; Asmus G; Hüfler M; Offermann G; Cremer H; Heuck CC; Ritz E
Artif Organs; 1978 Nov; 2(4):386-94. PubMed ID: 743012
[TBL] [Abstract][Full Text] [Related]
28. Uremic vagal neuropathy: has parathyroid hormone a pathogenetic role?
Vita G; Savica V; Calabrò R; Padovano I; Manna L; Toscano A; Rotondo S; Bellinghieri G
Funct Neurol; 1986; 1(3):253-9. PubMed ID: 3609857
[TBL] [Abstract][Full Text] [Related]
29. Residual renal function plays an important role in regulating parathyroid hormone in patients on continuous ambulatory peritoneal dialysis.
Okada S; Inoue T; Nakamoto H; Ikeda N; Sugahara S; Shoda J; Okada H; Kanno Y; Suzuki H
Adv Perit Dial; 2007; 23():150-4. PubMed ID: 17886623
[TBL] [Abstract][Full Text] [Related]
30. Effect of sevelamer on mineral and lipid abnormalities in hemodialysis patients.
Hamida FB; Fatma LB; Barbouch S; Kaaroud H; Helal I; Hedri H; Abdallah TB; Maiz HB; Kheder A
Saudi J Kidney Dis Transpl; 2008 Mar; 19(2):183-8. PubMed ID: 18310864
[TBL] [Abstract][Full Text] [Related]
31. How many measurements to make a decision?
Houillier P; Coste J; Froissart M
Clin J Am Soc Nephrol; 2010 Jul; 5(7):1161-2. PubMed ID: 20558565
[No Abstract] [Full Text] [Related]
32. [Evaluation of polyneuropathy severity in chronic renal failure patients on continuous ambulatory peritoneal dialysis or on maintenance hemodialysis].
Janda K; Stompór T; Gryz E; Szczudlik A; Drozdz M; Kraśniak A; Sułowicz W
Przegl Lek; 2007; 64(6):423-30. PubMed ID: 18159852
[TBL] [Abstract][Full Text] [Related]
33. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
Lee SH; Huang TS; Hsieh SJ
Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
[TBL] [Abstract][Full Text] [Related]
34. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
Toussaint ND; Polkinghorne KR; Kerr PG; Somerville CA; Agar JW
Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
[TBL] [Abstract][Full Text] [Related]
35. Effects of diabetes mellitus, age, and duration of dialysis on parathormone in chronic hemodialysis patients.
Nasri H; Kheiri S
Saudi J Kidney Dis Transpl; 2008 Jul; 19(4):608-13. PubMed ID: 18580021
[TBL] [Abstract][Full Text] [Related]
36. Serum parathyroid hormone concentration in chronic renal failure patients on maintenance haemodialysis.
Wills MR; Fairney A; Varghese Z; Tatler GL; Baillod RA; Moorhead JF
Clin Chim Acta; 1974 Nov; 57(1):83-9. PubMed ID: 4430145
[No Abstract] [Full Text] [Related]
37. Diagnosing hypovitaminosis D: serum measurements of calcium, phosphate, and alkaline phosphatase are unreliable, even in the presence of secondary hyperparathyroidism.
Smith GR; Collinson PO; Kiely PD
J Rheumatol; 2005 Apr; 32(4):684-9. PubMed ID: 15801026
[TBL] [Abstract][Full Text] [Related]
38. RenaGel efficacy in severe secondary hyperparathyroidism.
Castro R; Herman A; Ferreira C; Travassos F; Nunes-Azevedo J; Oliveira M
Nefrologia; 2002; 22(5):448-55. PubMed ID: 12497746
[TBL] [Abstract][Full Text] [Related]
39. [Absence of augmentation of the rate of motor nerve conduction following parathyroidectomy in hemodialysed uremic patients (proceedings)].
Drüeke T; Chkoff N; Di Guilio S; Zingraff J; Delons S; Man NK; Jungers P; Crosnier J
J Urol Nephrol (Paris); 1979; 85(4-5):335. PubMed ID: 480448
[No Abstract] [Full Text] [Related]
40. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
Hamano T; Oseto S; Fujii N; Ito T; Katayama M; Horio M; Imai E; Hori M
Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
